Mishra Shiraz I, Scherer Roberta W, Geigle Paula M, Berlanstein Debra R, Topaloglu Ozlem, Gotay Carolyn C, Snyder Claire
University of New Mexico, Albuquerque, NM, USA.
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD007566. doi: 10.1002/14651858.CD007566.pub2.
Cancer survivors experience numerous disease and treatment-related adverse outcomes and poorer health-related quality of life (HRQoL). Exercise interventions are hypothesized to alleviate these adverse outcomes. HRQoL and its domains are important measures for cancer survivorship.
To evaluate the effectiveness of exercise on overall HRQoL and HRQoL domains among adult post-treatment cancer survivors.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, MEDLINE, EMBASE, CINAHL, PsycINFO, PEDRO, LILACS, SIGLE, SportDiscus, OTSeeker, and Sociological Abstracts from inception to October 2011 with no language or date restrictions. We also searched citations through Web of Science and Scopus, PubMed's related article feature, and several websites. We reviewed reference lists of included trials and other reviews in the field.
We included all randomized controlled trials (RCTs) and controlled clinical trials (CCTs) comparing exercise interventions with usual care or other nonexercise intervention to assess overall HRQoL or at least one HRQoL domain in adults. Included trials tested exercise interventions that were initiated after completion of active cancer treatment. We excluded trials including people who were terminally ill, or receiving hospice care, or both, and where the majority of trial participants were undergoing active treatment for either the primary or recurrent cancer.
Five paired review authors independently extracted information on characteristics of included trials, data on effects of the intervention, and assessed risk of bias based on predefined criteria. Where possible, meta-analyses results were performed for HRQoL and HRQoL domains for the reported difference between baseline values and follow-up values using standardized mean differences (SMD) and a random-effects model by length of follow-up. We also reported the SMDs between mean follow-up values of exercise and control group. Because investigators used many different HRQoL and HRQoL domain instruments and often more than one for the same domain, we selected the more commonly used instrument to include in the SMD meta-analyses. We also report the mean difference for each type of instrument separately.
We included 40 trials with 3694 participants randomized to an exercise (n = 1927) or comparison (n = 1764) group. Cancer diagnoses in study participants included breast, colorectal, head and neck, lymphoma, and other. Thirty trials were conducted among participants who had completed active treatment for their primary or recurrent cancer and 10 trials included participants both during and post cancer treatment. Mode of the exercise intervention included strength training, resistance training, walking, cycling, yoga, Qigong, or Tai Chi. HRQoL and its domains were measured using a wide range of measures.The results suggested that exercise compared with control has a positive impact on HRQoL and certain HRQoL domains. Exercise resulted in improvement in: global HRQoL at 12 weeks' (SMD 0.48; 95% confidence interval (CI) 0.16 to 0.81) and 6 months' (0.46; 95% CI 0.09 to 0.84) follow-up, breast cancer concerns between 12 weeks' and 6 months' follow-up (SMD 0.99; 95% CI 0.41 to 1.57), body image/self-esteem when assessed using the Rosenberg Self-Esteem scale at 12 weeks (MD 4.50; 95% CI 3.40 to 5.60) and between 12 weeks' and 6 months' (mean difference (MD) 2.70; 95% CI 0.73 to 4.67) follow-up, emotional well-being at 12 weeks' follow-up (SMD 0.33; 95% CI 0.05 to 0.61), sexuality at 6 months' follow-up (SMD 0.40; 95% CI 0.11 to 0.68), sleep disturbance when comparing follow-up values by comparison group at 12 weeks' follow-up (SMD -0.46; 95% CI -0.72 to -0.20), and social functioning at 12 weeks' (SMD 0.45; 95% CI 0.02 to 0.87) and 6 months' (SMD 0.49; 95% CI 0.11 to 0.87) follow-up. Further, exercise interventions resulted in decreased anxiety at 12 weeks' follow-up (SMD -0.26; 95% CI -0.07 to -0.44), fatigue at 12 weeks' (SMD -0.82; 95% CI -1.50 to -0.14) and between 12 weeks' and 6 months' (SMD -0.42; 95% CI -0.02 to -0.83) follow-up, and pain at 12 weeks' follow-up (SMD -0.29; 95% CI -0.55 to -0.04) when comparing follow-up values by comparison group.Positive trends and impact of exercise intervention existed for depression and body image (when analyzing combined instruments); however, because few studies measured these outcomes the robustness of findings is uncertain.No conclusions can be drawn regarding the effects of exercise interventions on HRQoL domains of cognitive function, physical functioning, general health perspective, role function, and spirituality.Results of the review need to be interpreted cautiously owing to the risk of bias. All the trials reviewed were at high risk for performance bias. In addition, the majority of trials were at high risk for detection, attrition, and selection bias.
AUTHORS' CONCLUSIONS: This systematic review indicates that exercise may have beneficial effects on HRQoL and certain HRQoL domains including cancer-specific concerns (e.g. breast cancer), body image/self-esteem, emotional well-being, sexuality, sleep disturbance, social functioning, anxiety, fatigue, and pain at varying follow-up periods. The positive results must be interpreted cautiously due to the heterogeneity of exercise programs tested and measures used to assess HRQoL and HRQoL domains, and the risk of bias in many trials. Further research is required to investigate how to sustain positive effects of exercise over time and to determine essential attributes of exercise (mode, intensity, frequency, duration, timing) by cancer type and cancer treatment for optimal effects on HRQoL and its domains.
癌症幸存者经历了众多与疾病和治疗相关的不良后果,且健康相关生活质量(HRQoL)较差。运动干预被认为可以缓解这些不良后果。HRQoL及其各个领域是癌症幸存者的重要衡量指标。
评估运动对成年癌症治疗后幸存者的总体HRQoL及其各个领域的有效性。
我们检索了Cochrane对照试验中心注册库(CENTRAL)、PubMed、MEDLINE、EMBASE、CINAHL、PsycINFO、PEDRO、LILACS、SIGLE、SportDiscus、OTSeeker和Sociological Abstracts,检索时间从数据库建库至2011年10月,无语言或日期限制。我们还通过Web of Science、Scopus、PubMed的相关文章功能以及几个网站检索了参考文献。我们查阅了纳入试验的参考文献列表以及该领域的其他综述。
我们纳入了所有比较运动干预与常规护理或其他非运动干预,以评估成年人总体HRQoL或至少一个HRQoL领域的随机对照试验(RCT)和对照临床试验(CCT)。纳入的试验测试了在积极癌症治疗完成后开始的运动干预。我们排除了包括绝症患者、接受临终关怀护理的患者或两者兼有的患者的试验,以及大多数试验参与者正在接受原发性或复发性癌症积极治疗的试验。
五名配对的综述作者独立提取了纳入试验的特征信息、干预效果数据,并根据预定义标准评估了偏倚风险。在可能的情况下,使用标准化均数差(SMD)和随机效应模型,根据随访时间对报告的基线值和随访值之间的差异进行HRQoL及其领域的Meta分析。我们还报告了运动组和对照组平均随访值之间的SMD。由于研究人员使用了许多不同的HRQoL及其领域的工具,并且同一领域通常使用不止一种工具,我们选择了更常用的工具纳入SMD Meta分析。我们还分别报告了每种工具类型的平均差异。
我们纳入了40项试验,3694名参与者被随机分配到运动组(n = 1927)或对照组(n = 1764)。研究参与者的癌症诊断包括乳腺癌、结直肠癌、头颈癌、淋巴瘤等。30项试验是在完成原发性或复发性癌症积极治疗的参与者中进行的,10项试验包括癌症治疗期间和治疗后的参与者。运动干预方式包括力量训练、阻力训练、步行、骑自行车、瑜伽、气功或太极拳。使用了多种测量方法来测量HRQoL及其领域。结果表明,与对照组相比,运动对HRQoL及其某些领域有积极影响。运动导致以下方面得到改善:12周(SMD 0.48;95%置信区间(CI)0.16至0.81)和6个月(0.46;95%CI 0.09至0.84)随访时的总体HRQoL,12周和6个月随访期间的乳腺癌相关问题(SMD 0.99;95%CI 0.41至1.57),使用罗森伯格自尊量表在12周时(MD 4.50;95%CI 3.40至5.60)以及12周和6个月随访期间(平均差异(MD)2.70;95%CI 0.73至4.67)评估的身体形象/自尊,12周随访时的情绪健康(SMD 0.33;95%CI 0.05至0.61),6个月随访时的性功能(SMD 0.40;95%CI 0.11至0.68),在12周随访时比较对照组随访值时的睡眠障碍(SMD -0.46;95%CI -0.72至-0.20),以及12周(SMD 0.45;95%CI 0.02至0.87)和6个月(SMD 0.49;95%CI 0.11至0.87)随访时的社会功能。此外根据对照组随访值比较,运动干预导致12周随访时焦虑降低(SMD -0.26;95%CI -0.07至-0.44),12周时(SMD -0.82;95%CI -第1.50至-0.14)以及12周和6个月随访期间(SMD -0.42;95%CI -0.02至-0.83)疲劳降低,12周随访时疼痛降低(SMD -0.29;第95%CI -0.55至-0.04)。运动干预对抑郁和身体形象(分析综合工具时)存在积极趋势和影响;然而,由于很少有研究测量这些结果,研究结果的稳健性尚不确定。关于运动干预对认知功能、身体功能、总体健康观念、角色功能和精神性等HRQoL领域的影响,无法得出结论。由于存在偏倚风险,本综述结果需要谨慎解释。所有纳入综述的试验在实施偏倚方面风险较高。此外,大多数试验在检测、失访和选择偏倚方面风险较高。
本系统综述表明,运动可能对HRQoL及其某些领域有有益影响,包括特定癌症相关问题(如乳腺癌)、身体形象/自尊、情绪健康、性功能、睡眠障碍、社会功能、焦虑、疲劳和不同随访期的疼痛。由于所测试的运动方案和用于评估HRQoL及其领域的测量方法存在异质性,以及许多试验存在偏倚风险,因此对这些积极结果必须谨慎解释。需要进一步研究以探讨如何随着时间推移维持运动的积极效果,并根据癌症类型和癌症治疗确定运动的基本属性(方式、强度、频率、持续时间、时间),以对HRQoL及其领域产生最佳效果。